Actoplus Met - pioglitazone hydrochloride and metformin hydrochloride
Navigation: NDC > Supplier starting with: C > CARDINAL HEALTH| Field | Value |
|---|---|
| NDC Code: | 55154-5153 |
| Proprietary Name: | Actoplus Met |
| Suffix: | |
| Non-Proprietary Name: | pioglitazone hydrochloride and metformin hydrochloride |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 29-08-2005 |
| Category Name: | NDA |
| Application Number: | NDA021842 |
| Labeler: | CARDINAL HEALTH |
| Substance Name: | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
| Active Numerator Strength: | 850; 15 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
| DEA Schedule: |